South Africa’s Afrigen Biologics & Vaccines Ltd. is receiving global applause after the company said it had made a Covid-19 vaccine that matches the one by Moderna Inc. which rebuffed its request for a partnership. Afrigen, part of the World Health Organization’s mRNA technology transfer
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp